Search Login Register

Fibrinogen (Factor I) Summary

Description: Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products.

Also Known As: Factor I; Blood Coagulation Factor I; gamma-Fibrinogen; Factor I, Coagulation; I, Coagulation Factor Show All >>

Networked: 10189 relevant articles (263 outcomes, 1183 trials/studies) for this Drug

Key Diseases for which Fibrinogen is Relevant

  1. Hemorrhage : 37 outcomes 67 studies in 717 results
  2. Neoplasms (Cancer) : 16 outcomes 50 studies in 475 results
  3. Thrombosis (Thrombus) : 15 outcomes 39 studies in 803 results
  4. Wounds and Injuries (Trauma) : 14 outcomes 26 studies in 265 results
  5. Stroke (Strokes) : 9 outcomes 98 studies in 421 results
Show All >>

Drugs Related to Fibrinogen

  1. C-Reactive Protein
  2. Fibrin
  3. Thrombin
  4. Heparin (Liquaemin)
  5. fibrin fragment D (D-dimer)
  6. Plasminogen Activators (Plasminogen Activator)
  7. LDL Cholesterol
  8. Antithrombin III
  9. Cholesterol
  10. Insulin (Novolin)
Show All >>

Therapies Related to Fibrinogen

  1. Blood Component Removal (Apheresis)
  2. Transplants (Transplant)
  3. Plasmapheresis
  4. Spinal Fusion (Spondylosyndesis)
  5. Lasers (Laser)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.